La AGP supports custom in Alzheimer diagnosis

21 September day world of Alzheimer’s.

-en priority not only meet, but analyze in depth are the main needs of the person concerned

-La Confederation Española of associations of relatives of people with Alzheimer’s disease and other dementias (CEAFA) claimed a State policy, Alzheimer

-the average cost per person on Spain Alzheimer’s care amounts to 30,000 euros a year

Madrid, 2011-September in celebration of today, Wednesday 21 September, the day world of Alzheimer, the General Alliance of patients (AGP) wants to support one of the main claims of the group affected and their families: the need to provide a diagnosis personalized to each patient. The patient with Alzheimer’s disease should be the axis around which they have absolutely turn all efforts and inspire all the steps that have to be taken to improve not only their quality of life, but also of those who serve you and care every day.

Therefore, is a priority not only meet, but analyze in depth are the main needs of the person concerned, and only in this way you can define a framework of appropriate and effective support. Well, the motto chosen for this year’s world day every diagnosis, a person ” responds to this critical need.

And to meet this priority the Spanish Confederation of associations of relatives of people with Alzheimer’s disease and other dementias (CEAFA), Association as part of the PGA, claimed a policy state of Alzheimer’s, that considers the disease as a socio-health priority of the first magnitude in national politics. This policy must be focused on people affected by Alzheimer’s disease, who will be responsible for establishing the aspects that must be seen in relation to the socio-sanitary services, legal protection, research, as well as training and training of professionals ”, says Arsène HuerosPresident of CEAFA. In addition, Hueros warns that to society is ever more concerned about the disease, is getting used to the major figures, as the 3.5 million affected or the 24,000 EUR million posed today care of Alzheimer’s in Spain (annual per person € 30,000) and which is expected to reach 48 billion in a couple of decades ”.

Institutional and tenth Lottery Awards

On the other hand, on the occasion of the World Alzheimer’s day, CEAFA has celebrated the delivery of their institutional Awards V, which recognizes institutions that have more prominent throughout the year for his involvement with the affected. On this occasion the awards have been awarded, in the form of information, to Radio Televisión Española; in the form of research, the consortium of the international year of the research in Alzheimer’s disease 2011; in the category of caregiver, to the Commission for health, Social policy and consumption of the Senate, have urged the Government to the development of a strategy of Alzheimer’s disease based on the principles of equity and territorial cohesion, as well as for the support given to the Alliance by Alzheimer’s disease in general and CEAFA in particular; and in the Social category, the Association of relatives of Alzheimer’s sufferers and other neurological problems of the age in Merindades (AFAMER). This recognition is the result of the positive assessment that the Governing Board of CEAFA makes his merits report presented at open call. In addition, he has given a special recognition Oskar Weaver, director of the documentary caregivers.

Finally, the state lotteries and betting the State collaborated with CEAFA on promotion and awareness of the World Alzheimer’s day including the corporate image of this partnership, together with the motto each diagnosis, a person ”, in tenths of the national lottery draw on Saturday September 17.

On the General Alliance of patients

The General Alliance of patients (AGP) encompasses entities and Spanish sanitary institutions in various fields. It has been created with the intention of promoting the dialogue of the organizations of patients with health administrations, professionals in the same area and private entities.

The main mission of the PGA is to provide patient organisations of mechanisms for participation in healthcare decisions. To this end, PGA seeks to facilitate dialogue between health professionals, public administrations, private health sector companies and organizations themselves of patients, sharing objectives, improvement opportunities and problems to solve.

PGA is constituted as a platform for dialogue around patients, using criteria of quality and transparency.

About Alzheimer’s

Alzheimer’s disease is a neurodegenerative disease, progressive and irreversible, that causes loss of neurons and the deterioration of the physical and mental faculties of who her suffering. The name comes from the German neurologist Aloís Alzheimer who, in 1907, discovered the symptoms that characterize the disease. At the beginning, the disease appears slowly, with mild loss of memory, loss of fluency in verbal language, guidance failures, swings of mood and clear changes in personality, among other signs, and is advancing gradually until you reach the total disability and loss of mental and physical faculties, requiring the patient constant in their daily lives. There is currently no cure but there are treatments that attempt to reduce the level of progression of the disease and its symptoms. Treatment, palliative, settles with drugs, psychological help and personal care, responsibility falls in large number of cases in the relatives of the sick.